![](/img/cover-not-exists.png)
Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment*
Vincent, Jean-Louis, Bernard, Gordon R., Beale, Richard, Doig, Christopher, Putensen, Christian, Dhainaut, Jean-Francois, Artigas, Antonio, Fumagalli, Roberto, Macias, William, Wright, Theressa, Wong,Volume:
33
Language:
english
Journal:
Critical Care Medicine
DOI:
10.1097/01.CCM.0000181729.46010.83
Date:
October, 2005
File:
PDF, 571 KB
english, 2005